Psychopharmacology 2004: Vol 174 Table of Contents

2004·1.5 MB·English

Psychopharmacology
This journal was founded as Editors), J.O. Cole, J. Gerlach, M. Hamilton, J. Robbins, D.R. Sibley, D.M. Warburton, H. de Wit.
Psychopharmacologia in 1959 and was renamed Leysen, F. Sulser. As of Vol. 85 (1985): H. Barry As of Vol. 142 (1999): P.J. Cowen, J. Gerlach, M.A.
Psychopharmacology beginning with Ill, D.E. Casey, J.O. Cole, J. Gerlach, $.D. Glick, Geyer, A.R. Green, J.H. Krystal, J. Leysen, K.A
Vol. 46 (1976). A.R. Green, M. Hamilton, J. Leysen, T.W. Robbins, Miczek, T.W. Robbins, D.R. Sibley, D.M
The journal has been edited by the following F. Sulser. As of Vol. 92 (1987): H. Barry III, D.E. Warburton, H. de Wit. As of Vol. 151 (2000): PJ
Managing Editors Casey, J.Gerlach, S.D. Glick, A.R. Green, J. Cowen, J. Gerlach, M.A. Geyer, A.R. Green, J.H.
Leysen, T.W. Robbins, B.J. Spring, F. Sulser, D.M. Krystal, K.A. Miczek, T.W. Robbins, D.R. Sibley,
Vol. 1 (1959), E. Rothlin and A. Wikler; Vol. 2
Warburton. As of Vol. 98 (1989): H. Barry III, D.E. D.M. Warburton, H. de Wit. As of Vol. 152 (2000):
(1961), E. Rothlin and H. Isbell; Vol. 3 (1962),
Casey, J. Gerlach, $.D. Glick, A.R. Green, J. P.J. Cowen, J. Gerlach, M.A. Geyer, A.R. Green, D
E. Rothlin and A. Wikler: Vol. 4 (1963)—Vol. 7
Leysen, T.W. Robbins, D.R. Sibley, B.J. Spring, Hoyer, J.H. Krystal, K.A. Miczek, T.W. Robbins,
(1965), J.O. Cole and E. Rothlin; Vol. 8
D.M. Warburton. As of Vol. 106 (1992): D.E. D.R. Sibley, D.M. Warburton, H. de Wit. As of Vol
(1965)—Vol. 16 (1969), J.O. Cole, E. Jacobsen,
Casey, J. Gerlach, M.A. Geyer, A.R. Green, J. 167/2 (2003): P.J. Cowen, M.A. Geyer, A.R. Green,
M.E. Jarvik, M. Shepherd; Vol. 17 (1970), J.O.
Leysen, K.A. Miczek, T.W. Robbins, D.R. Sibley, D. Hoyer, J.H. Krystal, K.A. Miczek, T.W
Cole, E. Jacobsen, C. Kornetzky, M. Shepherd; B.J. Spring, D.M. Warburton. As of Vol. 109 Robbins, D.R. Sibley, D.M. Warburton, H. de Wit.
Vol. 18 (1970)—Vol. 27 (1972), J.O. Cole, M.
(1992): D.E. Casey, J. Gerlach, M.A. Geyer, A.R. As of Vol. 171/1 (2003): P.J. Cowen, V.H. Curran,
Hamilton, E. Jacobsen, C. Kornetzky; Vol. 2
Green, J. Leysen, K.A. Miczek, T.W. Robbins, M.A. Geyer, A.R. Green, D. Hoyer, J.H. Krystal,
(1973)—Vol. 35 (1974), J.O. Cole, M. Hamilton, E.
D.R. Sibley, B.J. Spring, D.M. Warburton, H. de U.A. Miczek, T.W. Robbins, D.R. Sibley, D.M
Jacobsen, C. Kornetzky, R.W. Russell; Vol. Wit Warburton, H. de Wit.
(1974)—Vol. 69 (1980), H. Barry III, J.O. Cole, !
As of Vol. 117 (1995): D.E. Casey, J As of Vol. 172/1 (2004): P.J. Cowen, H.V. Curran,
Hamilton, E Jacobsen, R.W. Russell: Vol. Gerlach, M.A. Geyer, A.R. Green, J. Leysen, M.A. Geyer, A.R. Green, D. Hoyer, J.H. Krystal,
(1980)—Vol. 77 (1982), H. Barry III, J.O. Cole, !
K.A. Miczek, T.W. Robbins, D.R. Sibley, D.M. K.A. Miczek, T.W. Robbins, D.R. Sibley, H. de Wit.
Hamilton, T.W. Robbins, R.W. Russell Warburton, H. de Wit. As of Vol. 129 (1997): D.E
Starting with Vol. 80 (1983) the Editors have Casey, P.J. Cowen, J. Gerlach, M.A. Geyer, A.R.
been: H. Barry III, T.W. Robbins (Coordinating Green, J. Leysen, K.A. Miczek, W. Potter, T.W.
Contents of Volume 174 2004
Arnold PD, Rosenberg DR, Mundo E, Berrettini W — Lerman C of working memory: insights for
Tharmalingam S, Kennedy JL, Besheer J, Lepoutre V, Hodge CW: targeting cognitive dysfunction
Richter MA: Association of a glutamate GABA, receptor agonists reduce in schizophrenia 111
(NMDA) subunit receptor gene operant ethanol self-administration Castner SA — Goldman-Rakic PS
(GRIN2B) with obsessive-compulsive and enhance ethanol sedation Catalano M — Serretti A
disorder: a preliminary study 530 in C57BL/6J mice 358 Cazala P — David V
Arnoldi A — Serretti A Birmingham AM -— Lile JA Chudasama Y, Robbins TW:
Arnsten AFT: Adrenergic targets for the Blaxton TA — Myers CS Psychopharmacological approaches
treatment of cognitive deficits in Blum AE — Roth BL to modulating attention in the
schizophrenia 25 Bowman EM — Wilson DIG five-choice serial reaction time task:
Artioli P — Serretti A Bogeso KP — Sanchez C implications for schizophrenia 86
Auerbach PP — Swerdlow NR Braestrup C — Sanchez C Clary CM — Durham LK
Avila MT — Myers CS Braff DL, Light GA: Preattentional and Codony X — Guitart X
attentional cognitive deficits as targets Cohrs S, Pohlmann K, Guan Z, Jordan W,
Baker GB —> Fletcher PJ for treating schizophrenia 75 Meier A, Huether G, Riither E,
Baker LE, Pynnonen D, Poling A: Bratton GR — Rocha A Rodenbeck A: Quetiapine reduces
Influence of reinforcer type and route of Brocco M — Millan MJ nocturnal urinary cortisol excretion
administration on gamma-hydroxybutyrate Brooks SP, Hennebry G, Croft AP, in healthy subjects 414
discrimination in rats 220 Thomas A, Little HJ: Effects Cohrs S, Rodenbeck A, Guan Z,
Bakos N — Haller J of corticosterone on place conditioning Pohlmann K, Jordan W, Meier A,
Baranyi J — Haller J toethanol 291 Riither E: Sleep-promoting properties
Barch DM: Pharmacological manipulation Brooks SP — Bensadoun J-C of quetiapine in healthy subjects 421
of human working memory 126 Bueno OFA — Pompéia S Colombo G — Carai MAM
Belluzzi JD, Lee AG, Oliff HS, Buhot M-C — David V Correll CU, Malhotra AK:
Leslie FM: Age-dependent effects Burton P + Kwiatkowska M Pharmacogenetics of antipsychotic-
of nicotine on locomotor activity and induced weight gain 477
conditioned place preference in rats Carai MAM, Vacca G, Serra S, ‘oyle JT, Tsai G: The NMDA
389 Colombo G, Froest!l W, Gessa GL: receptor glycine modulatory site:
Bender D > Marthi K Suppression of GABAg receptor a therapeutic target for improving
Bensadoun J-C, Brooks SP, Dunnett SB: function in vivo by disulfide reducing cognition and reducing negative
Free operant and discrete trial agent, DL-dithiothreitol (DTT) 283 symptoms in schizophrenia 32
performance of mice in the nine-hole Cardon AL — Rocha A ‘rabbe JC, Phillips TJ: Pharmacogenetic
box apparatus: validation using Castner SA, Goldman-Rakic PS, studies of alcohol self-administration
amphetamine and scopolamine 396 Williams GV: Animal models and withdrawal 539
IV
Croft AP — Brooks SP Geyer MA, Tamminga CA: Measurement Kwiatkowska M, Parker LA, Burton P,
Cropley M — Daniel J and treatment research to improve Mechoulam R: A comparative
Crystal-Mansour S — Lerman C cognition in schizophrenia: analysis of the potential of cannabinoids
Cubells JF, Zabetian CP: Human genetics neuropharmacological aspects | and ondansetron to suppress
of plasma dopamine B-hydroxylase Gobert A > Millan MJ cisplatin-induced emesis in the Suncus
activity: applications to research in Goins J — Swerdlow NR murinus (house musk shrew) 254
psychiatry and neurology 463 Goldman D — Heinz A
Cusin C — Serretti A Goldman-Rakic PS, Castner SA, Lee AG —> Belluzzi JD
Cussac D > Millan MJ Svensson TH, Siever LJ, Williams GV: Leonard DGB — Lerman C
Czoty PW, Morgan D, Shannon EE, Targeting the dopamine D, receptor Lepoutre V — Besheer J
Gage HD, Nader MA: Characterization in schizophrenia: insights for cognitive Lerman C, Berrettini W, Pinto A,
of dopamine D, and D, receptor function dysfunction 3 Patterson F, Crystal-Mansour S,
in socially housed cynomolgus monkeys Goldman-Rakic PS — Castner SA Wileyto EP, Restine SL, Leonard DGB,
self-administering cocaine 381 Guan Z — Cohrs S Shields PG, Epstein LH: Changes
Guard H — Eimer GI in food reward following smoking
Daniel J, Cropley M, Ussher M, West R: Guitart X, Codony X, Monroy X: cessation: a pharmacogenetic
Acute effects of a short bout of moderate Sigma receptors: biology and therapeutic investigation 571
versus light intensity exercise versus potential 301 Leslie FM — Belluzzi JD
inactivity on tobacco withdrawal Lewis DA, Volk DW, Hashimoto T:
symptoms in sedentary smokers 320 Halasz J — HallerJ Selective alterations in prefrontal
David V, Segu L, Buhot M-C, Ichaye M, Haller J, Baranyi J, Bakos N, Halasz J: cortical GABA neurotransmission
Cazala P: Rewarding effects elicited Social instability in female rats: in schizophrenia: a novel target for the
by cocaine microinjections into the effects on anxiety and buspirone efficacy treatment of working memory
ventral tegmental area of CS57BL/6 mice: 197 dysfunction 143
involvement of dopamine D, and Hanizavareh SM — Roth BL ight GA — Braff DL
serotonin), receptors 367 Hansen SB —> Marthi K ile JA, Morgan D, Birmingham AM,
Davies HML — Lile JA Harrison PJ: The hippocampus in Davies HML, Nader MA: Effects
Davis M — Meloni EG schizophrenia: a review of the of the dopamine reuptake inhibitor PTT
DiPietro N — Udo T neuropathological evidence and its on reinstatement and on food- and
Dunnett SB — Bensadoun J-C pathophysiological implications 151 cocaine-maintained responding in rhesus
Durham LK, Webb SM, Milos PM, Hashimoto T — Lewis DA monkeys 246
Clary CM, Seymour AB: The serotonin Heinz A, Goldman D, Gallinat J, Little HJ — Brooks SP
transporter polymorphism, SHTTLPR, Schumann G, Puls I: Pharmacogenetic Lorenzi C — Serretti A
is associated with a faster response time insights to monoaminergic dysfunction Lucchesi LM — Pompéia S
to sertraline in an elderly population in alcohol dependence 561
with major depressive disorder 525 Hennebry G > Brooks SP Malhotra AK, Krystal JH: Molecular
Hercher E —> Elmer GI genetics and psychopharmacology 439
bert B — Sanchez C Hermansen F — Marthi K Malhotra AK — Correll CU
ichenbaum HB — Udo T Hikiji K, Inoue K, Iwasaki S, Ichihara K, Manuck SB — Flory JD
‘llenbroek BA: Pre-attentive processing Kiriike N: Local perfusion of mCPP Manzano GM — Pompéia S
and schizophrenia: animal studies 65 into ventromedial hypothalamic nucleus, Marthi K, Jakobsen S, Bender D,
Imer GI, Sydnor J, Guard H, Hercher E, but not into lateral hypothalamic area Hansen SB, Smith SB, Hermansen F,
Vogel MW: Altered prepulse inhibition and frontal cortex, inhibits food intake Rosenberg R, Smith DF:
in rats treated prenatally with the inrats 190 |N-methyl-''C]Mirtazapine for positron
antimitotic Ara-C: an animal model for Hodge CW — Besheer J emission tomography neuroimaging
sensorimotor gating deficits in Holcomb HH: Practice, learning, and the of antidepressant actions in humans
schizophrenia 177 likelihood of making an error: how task 260
Epstein LH — Lerman C experience shapes physiological Martin LF, Kem WR, Freedman R:
response in patients with schizophrenia Alpha-7 nicotinic receptor agonists:
Fletcher PJ, Sinyard J, Salsali M, 136 potential new candidates for the
Baker GB: Fluoxetine, but not Huether G — Cohrs S treatment of schizophrenia 54
sertraline or citalopram, potentiates Megeehan AJ, Janak PH, Olive MF: Effect
the locomotor stimulant effect Ichaye M — David V of the mGluRS5 antagonist 6-methy]-2-
of cocaine: possible pharmacokinetic Ichihara K — Hikiji K (phenylethynyl)pyridine (MPEP) on the
effects 406 Inoue K — Hikiji K acute locomotor stimulant properties
Flory JD, Manuck SB, Perel JM, Iwasaki S > Hikiji K of cocaine, D-amphetamine, and the
Muldoon MF: A comparison of dopamine reuptake inhibitor GBR12909
d,/-fenfluramine and citalopram Jakobsen S — Marthi K in mice 266
challenges in healthy adults 376 Janak PH — Mcgeehan AJ McHugh-Strong C — Petrakis IL
Freedman R — Martin LF Jordan W — Cohrs S McMahon RP — Joy B
Friedman JI: Cholinergic targets Joy B, McMahon RP, Shepard PD: Mechoulam R — Kwiatkowska M
for cognitive enhancements in Effects of acute and chronic clozapine Meier A — Cohrs S
schizophrenia: focus on cholinesterase on D-amphetamine-induced disruption Meloni EG, Davis M: The substantia nigra
inhibitors and muscarinic agonists 45 of auditory gating in the rat 274 pars reticulata mediates the enhancement
Froest! W — Carai MAM of startle by the dopamine D, receptor
Kakoyannis AN — Myers CS agonist SKF 82958 in rats 228
Gage HD — Czoty PW Kaminski R — Gasior M Millan MJ, Seguin L, Gobert A,
Gallinat J — Heinz A Kantak KM — Udo T Cussac D, Brocco M: The role of
Gasior M, Kaminski R, Witkin JM: Kem WR —> Martin LF dopamine D, compared with D
Pharmacological modulation of GABA, Kennedy JL — Arnold PD receptors in the control of locomotor
receptors affects cocaine-induced Kiriike N — Hikiji K activity: a combined behavioural and
seizures in mice 211 Krystal JH — Malhotra AK neurochemical analysis with novel,
Gessa GL — Carai MAM Krystal JH — Petrakis IL selective antagonists in rats 341
Milos PM — Durham LK Robbins TW — Chudasama Y gating. Il. Temporal, pharmacologic
Moghaddam B: Targeting metabotropic Robles O — Myers CS and generational analyses of
glutamate receptors for treatment of the Rocha A, Valles R, Cardon AL, apomorphine effects on prepulse
cognitive symptoms of schizophrenia Bratton GR, Nation JR: inhibition 452
39 Self-administration of heroin in rats: Swerdlow NR, Shoemaker JM, Platten A,
Monroy X — Guitart X effects of low-level lead exposure Pitcher L, Goins J, Auerbach PP
Morgan D — Czoty PW during gestation and lactation 203 Heritable differences in the
Morgan D — Lile JA Rodenbeck A — Cohrs S dopaminergic regulation of sensorimotor
Muldoon MF — Flory JD Rosenberg DR —> Arnold PD gating. 1. Apomorphine effects on
Mundo E —> Arnold PD Rosenberg R — Marthi K startle gating in albino and hooded
Myers CS, Robles O, Kakoyannis AN, Rossini D — Serretti A outbred rat strains and their Fl and N2
Sherr JD, Avila MT, Blaxton TA, Roth BL, Hanizavareh SM, Blum AE: progeny 441
Thaker GK: Nicotine improves delayed Serotonin receptors represent highly Sydnor J > Elmer GI
recognition in schizophrenic patients favorable molecular targets for cognitive
334 enhancement in schizophrenia and other Tamminga CA — Geyer MA
disorders 17 Thaker GK — Myers CS
Nader MA — Czoty PW Rounsaville B —> Petrakis II Tharmalingam S — Arnold PD
Nader MA —> Lile JA Riither E — Cohrs S Thomas A — Brooks SP
Nation JR — Rocha A Tsai G > Coyle JT
Neumeister A, Young T, Stastny J: Salsali M — Fletcher PJ Tufik S — Pompéia S
Implications of genetic research Sanchez C, Béges¢@ KP, Ebert B,
on the role of the serotonin in Reines EH, Braestrup C: Escitalopram ido T, Ugalde F, DiPietro N,
depression: emphasis on the serotonin versus citalopram: the surprising role Eichenbaum HB, Kantak KM: Effects
type 1, receptor and the serotonin of the R-enantiomer 163 of persistent cocaine self-administration
transporter 512 Schumann G — Heinz A on amygdala-dependent and dorsal
Segu L — David V striatum-dependent learning in rats
Oliff HS — Belluzzi JD Seguin L > Millan MJ Jgalde F — Udo T
Olive MF — Mcgeehan AJ Serra S — Carai MAM Ussher M —> Daniel J
O’ Malley S — Petrakis IL Serretti A, Artioli P: From molecular
biology to pharmacogenetics: a review Vacca G > Carai MAM
Parker LA — Kwiatkowska M of the literature on antidepressant Valles R — Rocha A
Patterson F — Lerman C treatment and suggestions of possible Vogel MW —> Elmer GI
Perel JM — Flory JD candidate genes 490 Volk DW —> Lewis DA
Petrakis IL, O’ Malley S, Rounsaville B, Serretti A, Artioli P, Zanardi R, Lorenzi C,
Poling J, McHugh-Strong C, Krystal JH, Rossini D, Cusin C, Arnoldi A, Webb SM —> Durham LK
and VA Naltrexone Study Collaboration Catalano M: Genetic features of West R — Daniel J
Group: Naltrexone augmentation of antidepressant induced mania and Wileyto EP — Lerman C
neuroleptic treatment in alcohol abusing hypo-mania in bipolar disorder 504 Williams GV — Castner SA
patients with schizophrenia 300 Seymour AB — Durham LK Williams GV — Goldman-Rakic PS
Phillips TJ — Crabbe JC Shannon EE — Czoty PW Wilson DIG, Bowman EM: Second-order
Pinto A > Lerman C Shepard PD — Joy B stimuli do not always increase overall
Pitcher L — Swerdlow NR Sherr JD — Myers CS response rates in second-order schedules
Platten A — Swerdlow NR Shields PG — Lerman C of reinforcement in the rat 430, 438
PohImann K — Cohrs S Shoemaker JM — Swerdlow NR Witkin JM — Gasior M
Poling A — Baker LE Siever LJ — Goldman-Rakic PS
Poling J — Petrakis IL Sinyard J — Fletcher PJ Young T — Neumeister A
Pompéia S, Lucchesi LM, Bueno OFA, Smith DF — Marthi K
Manzano GM, Tufik S: Zolpidem Smith SB — Marthi K Zabetian CP — Cubells JF
and memory: a study using the process- Stastny J — Neumeister A Zanardi R — Serretti A
dissociation procedure 327 Svensson TH — Goldman-Rakic PS
Puls | — Heinz A Sweatt JD: Hippocampal function in
Pynnonen D — Baker LE cognition 99
Swerdlow NR, Shoemaker JM,
Reines EH > Sanchez C Auerbach PP, Pitcher L, Goins J, Indexed in/abstracted by Current Contents,
Restine SL > Lerman C Platten A: Heritable differences in the Psychological Abstracts, Psyc INFO,
Richter MA + Arnold PD dopaminergic regulation of sensorimotor Index Medicus and in EMBASE